Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Everest Medicines Limited
  6. Financials
    1952   KYG3224E1061

EVEREST MEDICINES LIMITED

(1952)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023
Capitalization1 16 70810 913--
Entreprise Value (EV)2 12 2487 8849 1057 587
P/E ratio -0,86x-10,2x-16,3x-18,3x
Yield ----
Capitalization / Revenue -5 694x14,0x6,93x
EV / Revenue -4 113x11,7x4,81x
EV / EBITDA -18,3x-9,93x-27,4x-14,6x
Price to Book 0,71x1,91x2,28x2,57x
Nbr of stocks (in thousands) 293 222297 970--
Reference price (CNY) 57,036,636,636,6
Announcement Date 03/22/2021---
1 HKD in Million
2 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 --1,927801 576
EBITDA1 --668-794-332-521
Operating profit (EBIT)1 --688-1 091-700-512
Operating Margin ---56 945%-89,8%-32,5%
Pre-Tax Profit (EBT)1 --5 658-1 096-523-323
Net income1 -215-5 658-1 046-586-506
Net margin ---54 576%-75,1%-32,1%
EPS2 -41,0-66,3-3,58-2,25-2,00
Dividend per Share2 -----
Announcement Date 09/20/202003/22/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2
Net sales1 ---6,7096,1
EBITDA -----
Operating profit (EBIT)1 --406-1 250-692-781
Operating Margin ----10 326%-813%
Pre-Tax Profit (EBT) -----
Net income -----
Net margin -----
EPS2 --1,31-4,07-2,27-2,54
Dividend per Share -----
Announcement Date 03/22/202108/30/2021---
1 CNY in Million
2 CNY
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 -4 4603 0291 8083 326
Leverage (Debt / EBITDA) -6,68x3,82x5,44x6,39x
Free Cash Flow1 --956-1 438-749-411
ROE (Net Profit / Equities) --189%-13,9%-11,1%-12,7%
Shareholders' equity1 -2 9907 5515 2883 973
ROA (Net Profit / Asset) --118%-17,5%-13,9%-21,2%
Assets1 -4 8075 9774 2172 386
Book Value Per Share2 -80,219,216,014,3
Cash Flow per Share2 --5,53-3,81-2,29-3,05
Capex1 -485517194196
Capex / Sales --26 974%24,9%12,4%
Announcement Date 09/20/202003/22/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (HKD) 13 200 093 017
Capitalization (USD) 1 696 896 888
Number of employees 227
Free-Float 98,1%
Free-Float capitalization (HKD) 12 947 216 241
Free-Float capitalization (USD) 1 664 389 101
Avg. Exchange 20 sessions (CNY) 14 020 551
Avg. Exchange 20 sessions (USD) 2 186 575
Average Daily Capital Traded 0,11%
EPS & Dividend